Zakrzewski Joseph S is a director of AN2 Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Cyteir Therapeutics, Inc.
8 Feb 24
4
AN2 Therapeutics, Inc.
19 Jan 24
144
AN2 Therapeutics, Inc.
18 Jan 24
4
AN2 Therapeutics, Inc.
9 Jun 23
4
Cyteir Therapeutics, Inc.
7 Feb 23
4/A
Cyteir Therapeutics, Inc.
8 Dec 22
4
Cyteir Therapeutics, Inc.
8 Dec 22
4
AN2 Therapeutics, Inc.
16 May 22
4
Cyteir Therapeutics, Inc.
16 May 22
4
Cyteir Therapeutics, Inc.
12 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Feb 24 | CYT Cyteir Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 1.69 | 14,150 | 23.91 k | 227,439 |
6 Feb 24 | CYT Cyteir Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.69 | 14,150 | 23.91 k | 0 |
18 Jan 24 | ANTX AN2 Therapeutics | Common Stock | Sell | Dispose S | Yes | No | 19.1141 | 100,000 | 1.91 mm | 405,880 |
7 Jun 23 | ANTX AN2 Therapeutics | Stock Option (right to buy) Common Stock | Grant | Acquire A | No | No | 5.91 | 23,742 | 140.32 k | 23,742 |
3 Feb 23 | CYT Cyteir Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.69 | 14,150 | 23.91 k | 14,150 |